These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11869267)

  • 1. Preclinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholesterolemic mice.
    Campbell LA; Moazed TC; Kuo CC; Grayston JT
    Clin Microbiol Infect; 1998 Jan; 4 Suppl 4():S23-S32. PubMed ID: 11869267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse.
    Moazed TC; Kuo CC; Grayston JT; Campbell LA
    J Infect Dis; 1998 May; 177(5):1322-5. PubMed ID: 9593019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine models of Chlamydia pneumoniae infection and atherosclerosis.
    Moazed TC; Kuo C; Grayston JT; Campbell LA
    J Infect Dis; 1997 Apr; 175(4):883-90. PubMed ID: 9086145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.
    Aalto-Setälä K; Laitinen K; Erkkilä L; Leinonen M; Jauhiainen M; Ehnholm C; Tamminen M; Puolakkainen M; Penttilä I; Saikku P
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):578-84. PubMed ID: 11304476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of C. pneumoniae infection and atherosclerosis.
    Campbell LA; Blessing E; Rosenfeld M; Lin Tm; Kuo C
    J Infect Dis; 2000 Jun; 181 Suppl 3():S508-13. PubMed ID: 10839749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae infection increases adherence of mouse macrophages to mouse endothelial cells in vitro and to aortas ex vivo.
    Takaoka N; Campbell LA; Lee A; Rosenfeld ME; Kuo CC
    Infect Immun; 2008 Feb; 76(2):510-4. PubMed ID: 18070891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Moazed TC; Campbell LA; Rosenfeld ME; Grayston JT; Kuo CC
    J Infect Dis; 1999 Jul; 180(1):238-41. PubMed ID: 10353889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice.
    Yang ZP; Kuo CC; Grayston JT
    J Infect Dis; 1995 Mar; 171(3):736-8. PubMed ID: 7876631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.
    Törmäkangas L; Alakärppä H; David DB; Leinonen M; Saikku P
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3655-61. PubMed ID: 15388416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient increase in atherosclerotic plaque macrophage content following
    Bazaz R; Marriott HM; Wright C; Chamberlain J; West LE; Gelsthorpe C; Heath PR; Maleki-Dizaji A; Francis SE; Dockrell DH
    Front Cell Infect Microbiol; 2023; 13():1090550. PubMed ID: 37033482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice.
    Blessing E; Campbell LA; Rosenfeld ME; Chough N; Kuo CC
    Atherosclerosis; 2001 Sep; 158(1):13-7. PubMed ID: 11500169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.
    Reis ED; Li J; Fayad ZA; Rong JX; Hansoty D; Aguinaldo JG; Fallon JT; Fisher EA
    J Vasc Surg; 2001 Sep; 34(3):541-7. PubMed ID: 11533609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
    Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
    Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae and vascular disease: an update.
    Mussa FF; Chai H; Wang X; Yao Q; Lumsden AB; Chen C
    J Vasc Surg; 2006 Jun; 43(6):1301-7. PubMed ID: 16765261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae.
    Hu H; Pierce GN; Zhong G
    J Clin Invest; 1999 Mar; 103(5):747-53. PubMed ID: 10074493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model.
    Madan M; Bishayi B; Hoge M; Amar S
    Atherosclerosis; 2008 Apr; 197(2):504-14. PubMed ID: 17412346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae and cardiovascular disease.
    Campbell LA; Kuo CC; Grayston JT
    Emerg Infect Dis; 1998; 4(4):571-9. PubMed ID: 9866733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
    Caligiuri G; Rottenberg M; Nicoletti A; Wigzell H; Hansson GK
    Circulation; 2001 Jun; 103(23):2834-8. PubMed ID: 11401941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental rabbit models of Chlamydia pneumoniae infection.
    Moazed TC; Kuo C; Patton DL; Grayston JT; Campbell LA
    Am J Pathol; 1996 Feb; 148(2):667-76. PubMed ID: 8579129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of exogenous fibroblast growth factor 21 on atherosclerosis in apolipoprotein E deficient mice].
    Wu X; Lü Y; Fu K; Wang S; Zhao D; Peng H; Fan Q; Lü Y; Xin M; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Feb; 42(2):126-31. PubMed ID: 24735623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.